Skip to main content

IBB

ETF
Health Care
Biotechnology

Performance overview

IBB Price
Price Chart

Forward-looking statistics

Beta
0.67
Risk
17.93%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

An ETF that tracks the performance of the biotechnology sector in the United States.

Fund info

An ETF that tracks the performance of the biotechnology sector in the United States.

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.45%
Asset classEquities

Company info

SectorHealth Care
IndustryBiotechnology
Website—
AUM$10.0B

Security info

ExchangeNASDAQ
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.48
Revenue per share—
Avg trading volume (30 day)$250M
Avg trading volume (10 day)$196M
Put-call ratioN/A

Macro factor sensitivity

Growth+0.7
Credit+3.1
Liquidity+0.2
Inflation-2.2
Commodities-0.2
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayMarch 18, 2025

News

Trump's deadline looms for Big Pharma companies facing new tariffs

'The Big Money Show' panel discusses President Donald Trump's pharmaceutical tariff strategy.

Fox Business (July 16, 2025)
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research (June 18, 2025)
Fast Money: WTI, IBB, UBER, CAT

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

CNBC Television (June 13, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free